CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia

We're sorry, your institution doesn't have access to this article through ProQuest.

You may have access to this article elsewhere through your library or institution, or try exploring related items you do have access to.

Suggested sources